Skip to NavigationSkip to content

News

New Jersey-based multinational MSD have announced that the European Commission (EC) has approved Simponi (golimumab) for early dose optimisation in...
The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the...
New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast cancer drug tamoxifen...
The Scottish Medicines Consortium has approved the use of EUSA Pharma’s Fotivda (tivozanib) as a first-line treatment for people with advanced...
California-based biotech Regulus Therapeutics has announced it is to strip away more than half of its total workforce as part of a strategic...
Teva has announced plans to relocate its North American headquarters from its current base in Philadelphia to Parsippany-Troy Hills, New Jersey,...
While the opioid epidemic has drawn GSK into a Massachusetts lawsuit and AbbVie is ordered to pay $448m, Abivax reveals drug able to reduce levels of...
Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol (THC) patch ZYN001 has failed in Phase 1 trials to achieve targeted...
A $55 million verdict against the multinational pharmaceutical company Johnson & Johnson has been overturned by an appeals court in Missouri.
Toronto, Ontario skyline
Illicit forms of the powerful opioid fentanyl have been driving increased rates of opioid-related deaths in the Canadian province of Ontario.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches